Ethiopia is transforming from an import-dependent market into a pharmaceutical manufacturing hub. After becoming the 9th African nation to reach WHO Maturity Level 3, local production now exceeds 40% of medicine supply. This WBG feature examines how regulation, the Kilinto Special Economic Zone, and research at AHRI and CDT-Africa are driving jobs, exports, and health sovereignty.